• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性射血分数降低型心力衰竭:流行病学、结局和治疗。

Heart Failure with Reduced Ejection Fraction in Women: Epidemiology, Outcomes, and Treatment.

机构信息

Pioneer Heart Institute, Cardiovascular Clinic of Nebraska, LLC, Lincoln, NE 68526, USA.

Heart and Vascular Institute, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, 9500 Euclid Avenue, J3-4, Cleveland, OH 44195, USA.

出版信息

Heart Fail Clin. 2019 Jan;15(1):19-27. doi: 10.1016/j.hfc.2018.08.003. Epub 2018 Oct 24.

DOI:10.1016/j.hfc.2018.08.003
PMID:30449377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6298793/
Abstract

There are millions of people affected by heart failure with reduced ejection fraction (HFrEF) as diagnosed with ejection fraction 40% or less by imaging. Established therapies have been proven through clinical trials on lifestyle interventions, medications, and devices for HFrEF to improve quality of life, heart function, and survival. Although there are more men than women suffering with HFrEF, there are no prospectively proven, sex-specific guideline therapies because women have been underrepresented in clinical trials. Current recommendations for medications in women with HFrEF are described in this article.

摘要

有数以百万计的人患有射血分数降低的心力衰竭(HFrEF),其通过影像学检查诊断为射血分数为 40%或更低。已通过临床试验证明,针对 HFrEF 的生活方式干预、药物和设备疗法可改善生活质量、心脏功能和生存率。尽管患有 HFrEF 的男性多于女性,但由于女性在临床试验中代表性不足,因此没有经过前瞻性证实的、性别特异性的指南治疗方法。本文描述了 HFrEF 女性患者的药物治疗建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dab/6298793/d63d85664205/nihms-998579-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dab/6298793/12f40e642716/nihms-998579-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dab/6298793/3a3b2906bf23/nihms-998579-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dab/6298793/859df970612c/nihms-998579-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dab/6298793/d63d85664205/nihms-998579-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dab/6298793/12f40e642716/nihms-998579-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dab/6298793/3a3b2906bf23/nihms-998579-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dab/6298793/859df970612c/nihms-998579-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dab/6298793/d63d85664205/nihms-998579-f0004.jpg

相似文献

1
Heart Failure with Reduced Ejection Fraction in Women: Epidemiology, Outcomes, and Treatment.女性射血分数降低型心力衰竭:流行病学、结局和治疗。
Heart Fail Clin. 2019 Jan;15(1):19-27. doi: 10.1016/j.hfc.2018.08.003. Epub 2018 Oct 24.
2
Heart Failure with Preserved Ejection Fraction in Women.女性射血分数保留型心力衰竭。
Heart Fail Clin. 2019 Jan;15(1):9-18. doi: 10.1016/j.hfc.2018.08.002.
3
Heart Failure in Women Due to Hypertensive Heart Disease.女性高血压性心脏病导致的心力衰竭。
Heart Fail Clin. 2019 Oct;15(4):497-507. doi: 10.1016/j.hfc.2019.06.002. Epub 2019 Aug 2.
4
Heart Failure in Women.女性心力衰竭
Methodist Debakey Cardiovasc J. 2017 Oct-Dec;13(4):216-223. doi: 10.14797/mdcj-13-4-216.
5
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.基于社区队列的射血分数保留与降低的心衰患者新发心衰的发病率和流行病学:PREVEND 的 11 年随访研究。
Eur Heart J. 2013 May;34(19):1424-31. doi: 10.1093/eurheartj/eht066. Epub 2013 Mar 6.
6
Heart Failure with Reduced Ejection Fraction-Does Sex Matter?射血分数降低型心力衰竭——性别重要吗?
Curr Heart Fail Rep. 2021 Dec;18(6):345-352. doi: 10.1007/s11897-021-00533-y. Epub 2021 Nov 15.
7
Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.心力衰竭与中等射血分数:射血分数恢复对运动耐量和预后的影响
Circ Heart Fail. 2016 Apr;9(4):e002826. doi: 10.1161/CIRCHEARTFAILURE.115.002826.
8
Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.冠心病患者的心力衰竭:患病率、特征及指南实施情况——德国EuroAspire IV队列研究结果
BMC Cardiovasc Disord. 2017 May 5;17(1):108. doi: 10.1186/s12872-017-0543-0.
9
Physical therapy in heart failure with preserved ejection fraction: A systematic review.射血分数保留的心力衰竭中的物理治疗:系统评价。
Eur J Prev Cardiol. 2016 Jan;23(1):4-13. doi: 10.1177/2047487314562740. Epub 2014 Dec 8.
10
Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.射血分数降低的心力衰竭的恢复和结局:一项前瞻性研究。
Eur J Heart Fail. 2017 Dec;19(12):1615-1623. doi: 10.1002/ejhf.824. Epub 2017 Apr 6.

引用本文的文献

1
Gender Differences in Disease Burden, Symptom Burden, and Quality of Life Among People Living With Heart Failure and Multimorbidity: Cross-Sectional Study.心力衰竭合并多种疾病患者的疾病负担、症状负担及生活质量的性别差异:横断面研究
J Adv Nurs. 2025 Feb 17. doi: 10.1111/jan.16797.
2
Stress echocardiography in heart failure patients: additive value and caveats.心力衰竭患者的超声心动图负荷试验:附加价值与注意事项。
Heart Fail Rev. 2024 Sep;29(5):1117-1133. doi: 10.1007/s10741-024-10423-9. Epub 2024 Jul 26.
3
Iron Deficiency: A Silent Threat in Patients With Heart Failure With Reduced Ejection Fraction.

本文引用的文献

1
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.心力衰竭伴射血分数保留、轻度降低和中度降低:5 年结局。
J Am Coll Cardiol. 2017 Nov 14;70(20):2476-2486. doi: 10.1016/j.jacc.2017.08.074. Epub 2017 Nov 12.
2
Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.肺动脉压指导心力衰竭伴射血分数降低患者的管理。
J Am Coll Cardiol. 2017 Oct 10;70(15):1875-1886. doi: 10.1016/j.jacc.2017.08.010.
3
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
缺铁:射血分数降低的心力衰竭患者中的隐匿威胁。
Cureus. 2024 Feb 4;16(2):e53542. doi: 10.7759/cureus.53542. eCollection 2024 Feb.
4
Differences in Health-Related Quality of Life among Patients with Heart Failure.心力衰竭患者健康相关生活质量的差异。
Medicina (Kaunas). 2024 Jan 6;60(1):109. doi: 10.3390/medicina60010109.
5
The Pathophysiology and New Advancements in the Pharmacologic and Exercise-Based Management of Heart Failure With Reduced Ejection Fraction: A Narrative Review.射血分数降低的心力衰竭的病理生理学以及基于药物和运动管理的新进展:一篇叙述性综述
Cureus. 2023 Sep 21;15(9):e45719. doi: 10.7759/cureus.45719. eCollection 2023 Sep.
6
Incidence, determinants, and outcomes of recovered left ventricular ejection fraction (LVEF) in patients with non-ischemic systolic heart failure; a hospital-based cohort study.非缺血性收缩性心力衰竭患者左心室射血分数(LVEF)恢复的发生率、决定因素和结局;一项基于医院的队列研究。
Indian Heart J. 2023 Mar-Apr;75(2):128-132. doi: 10.1016/j.ihj.2023.02.003. Epub 2023 Feb 22.
7
Participation of Older Adults in Clinical Trials for New Drug Applications and Biologics License Applications From 2010 Through 2019.2010 年至 2019 年新药申请和生物制品许可申请中老年人参与临床试验的情况。
JAMA Netw Open. 2022 Oct 3;5(10):e2236149. doi: 10.1001/jamanetworkopen.2022.36149.
8
Sex differences in efficacy of pharmacological therapies in heart failure with reduced ejection fraction: a meta-analysis.射血分数降低的心力衰竭中药物治疗疗效的性别差异:一项荟萃分析。
ESC Heart Fail. 2022 Aug;9(4):2753-2761. doi: 10.1002/ehf2.13974. Epub 2022 May 23.
9
The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women - Chapter 5: Sex- and Gender-Unique Manifestations of Cardiovascular Disease.加拿大女性心脏健康联盟关于女性心血管疾病流行病学、诊断与管理的图谱 - 第5章:心血管疾病的性别特异性表现
CJC Open. 2021 Nov 23;4(3):243-262. doi: 10.1016/j.cjco.2021.11.006. eCollection 2022 Mar.
10
Age and gender differences in diagnostic decision-making of early heart failure: results of a mixed-methods interview-study using video vignettes.年龄和性别对早期心力衰竭诊断决策的影响:使用视频小插曲的混合方法访谈研究的结果。
BMJ Open. 2022 Mar 10;12(3):e054025. doi: 10.1136/bmjopen-2021-054025.
生物标志物在心衰的预防、评估和管理中的作用:美国心脏协会的科学声明。
Circulation. 2017 May 30;135(22):e1054-e1091. doi: 10.1161/CIR.0000000000000490. Epub 2017 Apr 26.
4
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.《2017年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.
5
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.2016年美国心脏病学会/美国心脏协会/美国心力衰竭学会关于心力衰竭新药物治疗的重点更新:2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南更新:美国心脏病学会/美国心脏协会临床实践指南特别工作组及美国心力衰竭学会的报告
Circulation. 2016 Sep 27;134(13):e282-93. doi: 10.1161/CIR.0000000000000435. Epub 2016 May 20.
6
A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010.2000年至2010年明尼苏达州奥尔姆斯特德县心力衰竭流行情况的当代评估。
JAMA Intern Med. 2015 Jun;175(6):996-1004. doi: 10.1001/jamainternmed.2015.0924.
7
Angiotensin-neprilysin inhibition versus enalapril in heart failure.血管紧张素-脑啡肽酶抑制剂与依那普利治疗心力衰竭的比较。
N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.
8
Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.住院心力衰竭患者的性别、射血分数和 B 型利钠肽水平之间的关系及其与住院结局的相关性:来自 Get With The Guideline-Heart Failure 注册研究的结果。
Am Heart J. 2013 Dec;166(6):1063-1071.e3. doi: 10.1016/j.ahj.2013.08.029. Epub 2013 Oct 22.
9
Biomarkers in ACS and heart failure: should men and women be interpreted differently?ACS 和心力衰竭中的生物标志物:男女是否应该有不同的解读?
Clin Chem. 2014 Jan;60(1):35-43. doi: 10.1373/clinchem.2013.202531. Epub 2013 Nov 19.
10
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2013 Oct 15;128(16):e240-327. doi: 10.1161/CIR.0b013e31829e8776. Epub 2013 Jun 5.